What's new

Human medicines European public assessment report (EPAR): Rivastigmine 1 A Pharma, rivastigmine, Date of authorisation: 11/12/2009, Revision: 19, Status: Authorised

Human medicines European public assessment report (EPAR): Rivastigmine 1 A Pharma, rivastigmine, Date of authorisation: 11/12/2009, Revision: 19, Status: Authorised

Apr 4, 2025 - 13:49
 0
Human medicines European public assessment report (EPAR): Rivastigmine 1 A Pharma, rivastigmine, Date of authorisation: 11/12/2009, Revision: 19, Status: Authorised
Human medicines European public assessment report (EPAR): Rivastigmine 1 A Pharma, rivastigmine, Date of authorisation: 11/12/2009, Revision: 19, Status: Authorised
Read More

Tags:

Previous Article

Eurofragance renforce son équipe de parfumeurs maison avec Pelegrí Granel

Next Article

Charles Tyrwhitt names new brand ambassador

Related Posts

Applications for new human medicines under evaluation: ...

Feb 10, 2025  0

Decision on rules concerning the handling of declared i...

Mar 26, 2025  0

Call for scientific data for the periodic review of the...

Apr 1, 2025  0